{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:54:38Z","timestamp":1773449678937,"version":"3.50.1"},"reference-count":33,"publisher":"JLE","issue":"7","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.nephro.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T05:56:30Z","timestamp":1631685390000},"page":"507-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of renal effects of liposomal amphotericin B in children with malignancies with KDIGO and RIFLE criteria"],"prefix":"10.1684","volume":"17","author":[{"given":"Fatma","family":"Devrim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lknur","family":"\u00c7a\u011flar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan Okur","family":"Acar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eeyma","family":"Akku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nida","family":"Din\u00e7el","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neryal","family":"Tahta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beng\u00fc","family":"Demira\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba Hilkay","family":"Karap\u0131nar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"G\u00f6zmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye\u015fim","family":"Oymak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Vergin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lker","family":"Devrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2021.06.007_bib0170","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/504492","article-title":"Pharmacology of systemic antifungal agents","volume":"43","author":"Ashley","year":"2006","journal-title":"Clin Infec Dis"},{"key":"10.1016\/j.nephro.2021.06.007_bib0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome(\u00ae)): A review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.nephro.2021.06.007_bib0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4065\/mcp.2011.0247","article-title":"Current concepts in antifungal pharmacology","volume":"86","author":"Lewis","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nephro.2021.06.007_bib0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.nephro.2021.06.007_bib0190","article-title":"Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function","volume":"11","author":"Botero Aguirre","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nephro.2021.06.007_bib0195","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/archinte.1988.00380110049010","article-title":"Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation","volume":"148","author":"Branch","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nephro.2021.06.007_bib0200","unstructured":"Sawaya BP, Briggs JP, Schnermann J. Amphotericin B nephrotoxicity: The adverse consequences of altered membrane properties. J Am Soc Nephrol."},{"key":"10.1016\/j.nephro.2021.06.007_bib0205","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1046\/j.1523-1755.2001.00948.x","article-title":"Correlates of acute renal failure in patients receiving parenteral amphotericin B","volume":"60","author":"Bates","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2021.06.007_bib0210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9343(01)00928-7","article-title":"The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy","volume":"111","author":"Harbarth","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2021.06.007_bib0215","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/ki.1992.229","article-title":"Direct amphotericin B-mediated tubular toxicity: assessments of selected cytoprotective agents","volume":"41","author":"Zager","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2021.06.007_bib0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.V4169","article-title":"Chronic amphotericin nephropathy: Morphometric, electron microscopic, and functional studies","volume":"4","author":"Heyman","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2021.06.007_bib0225","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/AAC.45.3.679-685.2001","article-title":"Apoptosis contributes to amphotericin B-induced nephrotoxicity","volume":"45","author":"Varlam","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nephro.2021.06.007_bib0230","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0002-9343(83)90353-4","article-title":"Amphotericin B nephrotoxicity in humans decreased by salt repletion","volume":"75","author":"Heidemann","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2021.06.007_bib0235","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/cid\/cis290","article-title":"Does lipid emulsion reduce amphotericin B nephro- toxicity? A systematic review and meta-analysis","volume":"54","author":"Mistro","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2021.06.007_bib0240","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/jps.2600830716","article-title":"Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein","volume":"83","author":"Wasan","year":"1994","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nephro.2021.06.007_bib0245","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1023\/A:1007605024942","article-title":"Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats","volume":"17","author":"Bekersky","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.nephro.2021.06.007_bib0250","article-title":"Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections","volume":"2","author":"Blyth","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nephro.2021.06.007_bib0255","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/bcp.13521","article-title":"Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations","volume":"84","author":"Andrew","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nephro.2021.06.007_bib0260","unstructured":"Castillo L, Janic D, Jazbec APDJ, Kaiserova E, Konja J, Kovacs G, et al. ALL IC BFM 2009. www.bialaczka.org\/wp-content\/uploads\/2016\/10\/ALLIC_BFM_2009.pdf."},{"key":"10.1016\/j.nephro.2021.06.007_bib0265","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","article-title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel","volume":"120","author":"Creutzig","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2021.06.007_bib0270","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12098-013-0977-z","article-title":"A comparative study on reliability of point of care sodium and potassium estimation in a pediatric intensive care unit","volume":"80","author":"Chhapola","year":"2013","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.nephro.2021.06.007_bib0275","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-43596-0_12","article-title":"Physiology of the developing kidney: Fluid and electrolyte homeostasis and therapy of basic disorders. Springer-Verlag Berlin Heidelberg. Avner et al., eds","author":"Ashoor","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2021.06.007_bib0280","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00467-006-0358-1","article-title":"Glomerular filtration rate measurement and estimation in chronic kidney disease","volume":"22","author":"Schwartz","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2021.06.007_bib0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2015.01.023","article-title":"Intravenous acyclovir and renal dysfunction in children: a matched case control study","volume":"166","author":"Rao","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.nephro.2021.06.007_bib0290","unstructured":"KDIGO. Clinical practice guideline for acute kidney injury. https:\/\/kdigo.org\/wp-content\/uploads\/2016\/10\/KDIGO-2012-AKI-Guideline-English.pdf."},{"key":"10.1016\/j.nephro.2021.06.007_bib0295","article-title":"lipid soluble formulations versus amphotericin B in cancer patients with neutropenia (Review)","volume":"9","author":"Johansen","year":"2014","journal-title":"Cochrane Collab"},{"key":"10.1016\/j.nephro.2021.06.007_bib0300","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/341401","article-title":"A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients","volume":"35","author":"Bowden","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2021.06.007_bib0305","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-137-2-200207160-00008","article-title":"Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS","volume":"137","author":"Johnson","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2021.06.007_bib0310","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","article-title":"Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases","volume":"26","author":"Walsh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2021.06.007_bib0315","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.38.4.713","article-title":"Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits","volume":"38","author":"Lee","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nephro.2021.06.007_bib0320","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1023\/A:1018997730462","article-title":"Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome) in beagle dogs","volume":"16","author":"Bekersky","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.nephro.2021.06.007_bib0325","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3892\/etm.2014.1534","article-title":"Evaluation of hypokalemia and potassium supplementation during administration of liposomal-amphotericin B","volume":"7","author":"Usami","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.nephro.2021.06.007_bib0330","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/INF.0000000000001802","article-title":"Analysis of hypokalemia as a side effect of liposomal amphotericin in pediatric patients","volume":"37","author":"Kobayashi","year":"2018","journal-title":"Pediatr Infec Dis J"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725521001450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725521001450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2021.06.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:25:45Z","timestamp":1741191945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725521001450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1769725521001450"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2021.06.007","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of renal effects of liposomal amphotericin B in children with malignancies with KDIGO and RIFLE criteria","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}